Health and Nutrition Campaigns


September Nutrition, Health and Diet Alert

Write the FDA in Support of Caffeine Labeling

September 3, 1997

CSPI is urging concerned citizens to write the Food and Drug Administration (FDA) in support of our campaign to provide consumers with quantitative information about the caffeine content of foods and beverages. Contact the FDA and ask them to require that caffeine content be disclosed prominently on food labels of products that contain significant amounts of caffeine.

Caffeine poses a health risk to millions of Americans, especially women who are or might become pregnant. Caffeine increases the risks of infertility, miscarriage, and impaired fetal growth. It also affects bone health, exacerbating the low calcium intakes of women and teenagers, and increases the risk of osteoporosis. Additionally, millions of Americans experience unpleasant behavioral effects from caffeine such as addiction, withdrawal, anxiety, and sleeplessness.

As caffeinated products become more prevalent, and the marketing of those products to children increases, consumers need more information to take charge of their own and their family's health. Caffeine can show up in some surprising places and the caffeine content of similar types of products can vary widely. For example, some coffee yogurts have as much caffeine as half a cup of instant coffee, while others contain no caffeine. Consumers have a right to easy access to information about the caffeine content of foods so that they can make informed choices.

What You Can Do

Write the FDA today and urge them to require manufacturers to display caffeine content prominently on the labels of foods that contain significant amounts of caffeine. Suggestions for points to stress in your letter are attached.

Sincerely,

Patricia B. Lieberman, Ph.D.
Senior Science Policy Fellow



Points to make in your letter to the FDA on quantitative caffeine labeling.


Caffeine reduces the chance of getting pregnant. One study showed that the chances of taking more than a year to conceive are nearly five-times higher in women who consume more than 100 mg of caffeine per day than for women who drink less.

Caffeine increases the risk of miscarriage. Consuming more than 300 mg of caffeine may contribute to as many as 14% of miscarriages in the U.S.

Caffeine inhibits fetal growth and decreases a baby's birth weight. Low birth weight increases a baby's risk of illness and death.

require companies to provide quantitative caffeine information on nutrition labels.

conduct a study of caffeine's effects on health and behavior to determine if other regulatory or educational effort should be undertaken.

Dr. Dr. Michael Friedman, Lead Deputy Commissioner
Food and Drug Administration
Dockets Management Branch (HFA-305)
12420 Parklawn Drive Room 1-23
Rockville, MD 20857
Re: Docket #97P-0329

Or fax your letter to Dr. Friedman at 301-443-3100.


Nutrition Action Network

___ Yes, I sent a letter to the FDA in support of quantitative caffeine labeling. A copy of my letter is attached.

Name_________________________ Address_______________________________________ City/State/Zip________________________________________Phone____________________ Fax____________________ E-mail ______________________

Return to:

CSPI -- Nutrition Advocacy
1220 L St. N.W., Suite 300
Washington, D.C. 20005